Distribution in the pharmaceutical industry is far more complex than many other sectors, given the sensitive nature of the products involved. Pharmaceutical companies must manage regulatory compliance, ensure product…
Learn MoreInvestigational Medicinal Products (IMPs) to be used in an EU clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…
Learn MoreThe MHRA introduced the QP Oversight process for clinical supplies entering into Great Britain from the EU/EEA after Brexit. The Medicines for Human Use (Clinical Trial) Regulations 2004 requires that…
Learn MoreSecondary packaging and labelling of clinical trial material present unique challenges due to regulatory requirements, patient safety concerns, and logistical complexities. Navigating these challenges requires a comprehensive understanding of…
Learn MoreInvestigational Medicinal Products (IMPs) to be used in a UK clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…
Learn MoreInvestigational Medicinal Products (IMPs) to be used in an EU clinical trial must be certified by a Qualified Person (QP) named on a Manufacturing and Import Authorisation (MIA(IMP)) to ensure…
Learn MoreWhat is the UK QP oversight process for Investigational Medicinal Products? Sponsors of a UK clinical trial using IMPs imported into Great Britain from countries on an ‘approved country for…
Learn MorePNR are delighted to announce the MHRA approval of our new facility in Blaenau Gwent, South Wales. We hold MIA, MIA(IMP), MS and WDA licences which allow us to expand…
Learn MoreQualified Person (QP) Declaration in Clinical Trials. When developing a new drug, it is critical to ensure that it is safe and effective for use in humans. Clinical trials are…
Learn MoreWe are delighted to welcome Tony Pinney to PNR Pharma as Qualified Person. Tony has over 30 years’ experience within the Pharmaceutical Industry with various roles within Quality. After qualifying as a QP…
Learn MoreWe will email you to start the conversation